Related changes
← ALC-0159
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are shown in bold with a green bullet. See more at Help:Related changes.
List of abbreviations (help):
- D
- Edit made at Wikidata
- r
- Edit flagged by ORES
- N
- New page
- m
- Minor edit
- b
- Bot edit
- (±123)
- Page byte size change
- Temporarily watched page
8 April 2025
- diffhist BioNTech 12:04 +4,074 Kamilla Ralf talk contribs Tag: use of deprecated (unreliable) source
- diffhist BioNTech 12:00 +572 Kamilla Ralf talk contribs (→Oncology and international expansion (since 2021))
- diffhist Wikipedia:Stub 10:14 +90 GhostInTheMachine talk contribs (→See also: links on own lines, add a little detail)
7 April 2025
- diffhist m Pfizer 11:46 −10 Soorch talk contribs (→Partnership with Flagship Pioneering: Removed the duplicate word)
- diffhist Pfizer 11:42 +453 Soorch talk contribs (Expanded lead section, added source)
- diffhist Pfizer 11:23 +16 Soorch talk contribs (Updated infobox)
- diffhist Pfizer 11:01 +746 Soorch talk contribs (→Expanding AI Collaboration for Clinical Trials with Saama: Expanded, added source)
- diffhist Pfizer 10:45 +520 Soorch talk contribs (→History: Added Expanding AI Collaboration for Clinical Trials with Saama section)
- diffhist Pfizer 05:42 +506 Soorch talk contribs (→Pfizer's Global Recognitions: Expanded, added source, fixed ref code)
- diffhist Pfizer 05:29 +523 Soorch talk contribs (→Pfizer's Global Recognitions: Expanded section)
- diffhist Pfizer 05:15 +249 Soorch talk contribs (→Pfizer's Global Recognitions: Expanded section)
- diffhist Pfizer 04:55 +272 Soorch talk contribs (→The Royal Society Pfizer Award/The Royal Society Africa Prize: Expanded, added source)
- diffhist Pfizer 04:41 +490 Soorch talk contribs (→Public-private engagement: Added The Royal Society Pfizer Award/The Royal Society Africa Prize section)
6 April 2025
- diffhist Pfizer 20:10 +592 Soorch talk contribs (→Advances in AI, Gene Therapy, and Breakthrough Treatments: Added sources)
- diffhist Pfizer 20:00 +476 Soorch talk contribs (→Advances in AI, Gene Therapy, and Breakthrough Treatments: Expanded section)
- diffhist Pfizer 19:43 +388 Soorch talk contribs (→Advances in AI, Gene Therapy, and Breakthrough Treatments: Expanded section)
- diffhist Pfizer 19:32 +307 Soorch talk contribs (→Areas of Focus: Added Advances in AI, Gene Therapy, and Breakthrough Treatments section)
- diffhist Wikipedia:Stub 05:44 0 Yelps talk contribs (Up to date now) Tags: Mobile edit Mobile web edit Advanced mobile edit
5 April 2025
- diffhist Pfizer 12:10 +579 Soorch talk contribs (→Collaboration with Ignition AI Accelerator: Added sources)
- diffhist Pfizer 12:01 +537 Soorch talk contribs (→Partnership with Flagship Pioneering: Added Collaboration with Ignition AI Accelerator section)
4 April 2025
- diffhist Pharmacology 16:35 +29 GlobalMindSphere talk contribs (→Societies and education: punctuation and clarity)
- diffhist Pharmacology 16:10 −10 GlobalMindSphere talk contribs (→Pharmacokinetics: spacing, punctuation, clarity)
- diffhist Pharmacology 14:17 +30 GlobalMindSphere talk contribs (→Drug discovery: punctuation and clarity EMA)
3 April 2025
- diffhist Pfizer 23:21 +561 Soorch talk contribs (→Pfizer For All: Added sources)
- diffhist Pfizer 23:01 +495 Soorch talk contribs (→Pfizer For All: Expanded section)
- diffhist Pfizer 22:54 +278 Soorch talk contribs (→Public-private engagement: Added source)
- diffhist Pfizer 22:42 +311 Soorch talk contribs (→Philanthropy: Added Pfizer For All section)
2 April 2025
- diffhist Pfizer 19:24 +341 Soorch talk contribs (→Partnership with Flagship Pioneering: Expanded section)
- diffhist Pfizer 19:14 +253 Soorch talk contribs (→Late 2020–onwards: Corporate developments and acquisitions: Added source)
- diffhist Pfizer 19:08 +423 Soorch talk contribs (→Late 2020–onwards: Corporate developments and acquisitions: Updated section)
- diffhist Pfizer 18:53 +394 Soorch talk contribs (→Late 2020–onwards: Corporate developments and acquisitions: Updated section)